A revolutionary handheld and battery-powered DNA diagnostic device invented at the University of Otago is poised to become a commonly used field tool for rapidly detecting suspected viruses or bacteria in samples while also determining the level of infection.
The breakthrough device, dubbed Freedom4, will be unveiled today at the Queenstown Molecular Biology main meeting. It takes advantage of a technology called quantitative PCR to identify target DNA sequences in real-time, without the need for further processing.
As an example, using Freedom4, the presence and extent of norovirus infection in a sample could be confirmed within less than an hour, while the person using the unit was still at the outbreak site.
Dr Jo-Ann Stanton, who led the programme to develop the device, says that as well as enabling ‘anytime, anywhere’ clinical diagnosis of viral infectious diseases in humans and animals, it also has many other potential uses, such as border security, forensics or environmental monitoring.
Developed by Dr Stanton’s multidisciplinary team at Otago’s Department of Anatomy, the sturdy unit weighs the same as a typical laptop and fits on the palm of your hand. Freedom4 boasts a six-hour battery life and can be tethered to a laptop, or connect wirelessly to smart phones or tablets running custom software that analyses and interprets the test results.
“This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analysing samples from various locations, make their diagnoses and treat infected animals-all in one trip,” she says.
The Latest on: DNA diagnostics
[google_news title=”” keyword=”DNA diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: DNA diagnostics
- Global Next-Generation Gynecological Cancer Diagnostics Grows Steadily At A CAGR Of 10.68%on August 2, 2024 at 2:27 am
Uterine, ovarian, and cervical cervix cancers are the most common in women. Cervical cancer ranks fourth among women's cancers. Gynecological canc ...
- Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addictionon July 31, 2024 at 7:00 am
(“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced that Laboratory Services MSO, LLC (“LSM”) has ...
- Automated DNA nanotube synthesis method advances molecular engineering capabilitieson July 31, 2024 at 6:09 am
A new automated system for DNA nanotube synthesis combines microfluidics and single-molecule imaging, enabling rapid production and characterization of complex nanostructures.
- DNA Polymerase Market is anticipated to reach USD 647.5 Million by 2033, growing at a steady 6.2% CAGR | FMIon July 31, 2024 at 4:36 am
The world of scientific research is experiencing a surge in demand for DNA Polymerase. A recent analysis projects the global DNA Polymerase Market to reach a staggering USD 647.5 million by 2033, ...
- DNA data security requires robust protections, not rhetoricon July 31, 2024 at 1:30 am
The risks of the BIOSECURE Act's Whac-A-Mole approach affect companies today as well as people who may benefit from the research that will be conducted tomorrow.
- Global Chlamydia Diagnostics Market Set for Remarkable Growth: Projected to Reach USD 3.69 Billion by 2033on July 30, 2024 at 9:32 pm
Chlamydia Diagnostics Market soar to a remarkable USD 3.69 billion by 2033. This notable increase, driven by a CAGR of 11%.
- Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceabilityon July 24, 2024 at 11:11 pm
the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
- Quest Diagnostics' Haystack Oncology Forges New MRD Dealon July 24, 2024 at 11:16 am
Quest Diagnostics' (NYSE: DGX) subsidiary, Haystack Oncology, and Lisata Therapeutics, Inc. (NASDAQ: LSTA) recently announced a research collaboration for using the Haystack MRD (minimal residual ...
- DNA Diagnostics Market: $13.3B to $21.2B Growth Forecast (2024-2029) | MarketsandMarkets™on July 24, 2024 at 5:29 am
The "DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease ...
- Genetic diagnostics of ultra-rare diseaseson July 22, 2024 at 4:39 pm
The majority of rare diseases have a genetic cause. The underlying genetic alteration can be found more and more easily, for example by means of exome sequencing (ES), leading to a molecular genetic ...
via Bing News